These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22044661)

  • 21. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
    Reyes-Vallejo L; Lazarou S; Morgentaler A
    J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone and metabolic syndrome: a meta-analysis study.
    Corona G; Monami M; Rastrelli G; Aversa A; Tishova Y; Saad F; Lenzi A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2011 Jan; 8(1):272-83. PubMed ID: 20807333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone replacement therapy: Pre-treatment sex hormone-binding globulin levels and age may identify clinical subgroups.
    Ramachandran S; Hackett GI; Strange RC
    Andrology; 2020 Sep; 8(5):1222-1232. PubMed ID: 32384175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Sex Hormone Binding Globulin (SHBG) Relation with Different Components of Metabolic Syndrome in Men with Type 2 Diabetes.
    Siddiqui K; Al-Rubeaan K; Nawaz SS; Aburisheh KH; Alaabdin AMZ; Tolba IA
    Horm Metab Res; 2018 Feb; 50(2):138-144. PubMed ID: 29245159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.
    Traish AM; Haider A; Doros G; Saad F
    Int J Clin Pract; 2014 Mar; 68(3):314-29. PubMed ID: 24127736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of sex hormone-binding globulin and testosterone in the risk of incident metabolic syndrome.
    Haring R; Völzke H; Spielhagen C; Nauck M; Wallaschofski H
    Eur J Prev Cardiol; 2013 Dec; 20(6):1061-8. PubMed ID: 22711969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadal function is associated with cardiometabolic health in pre-pubertal boys with Klinefelter syndrome.
    Davis S; Lahlou N; Bardsley M; Temple MC; Kowal K; Pyle L; Zeitler P; Ross J
    Andrology; 2016 Nov; 4(6):1169-1177. PubMed ID: 27637014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
    Rhoden EL; Morgentaler A
    Int J Impot Res; 2006; 18(2):201-5. PubMed ID: 16177827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study.
    Li H; Mitchell L; Zhang X; Heiselman D; Motsko S
    J Sex Med; 2017 Nov; 14(11):1307-1317. PubMed ID: 29110802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
    Yassin DJ; Doros G; Hammerer PG; Yassin AA
    J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism.
    Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS
    Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-sectional association between testosterone, sex hormone-binding globulin and metabolic syndrome: The Healthy Twin Study.
    Moon H; Choi I; Kim S; Ko H; Shin J; Lee K; Sung J; Song YM
    Clin Endocrinol (Oxf); 2017 Nov; 87(5):523-531. PubMed ID: 28581026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone.
    Heufelder AE; Saad F; Bunck MC; Gooren L
    J Androl; 2009; 30(6):726-33. PubMed ID: 19578132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
    Lundy SD; Parekh NV; Shoskes DA
    J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism.
    Monroe AK; Dobs AS; Palella FJ; Kingsley LA; Witt MD; Brown TT
    AIDS Res Ther; 2014 Jan; 11(1):6. PubMed ID: 24450960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
    García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
    J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
    Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).
    Jones TH; Arver S; Behre HM; Buvat J; Meuleman E; Moncada I; Morales AM; Volterrani M; Yellowlees A; Howell JD; Channer KS;
    Diabetes Care; 2011 Apr; 34(4):828-37. PubMed ID: 21386088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total Testosterone to Estradiol Ratio as a Predictor Marker of Metabolic Syndrome in Males.
    Ali Hamza M; Abdulhameed A; Ali Mansour A
    Arch Razi Inst; 2022 Feb; 77(1):351-357. PubMed ID: 35891738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.